 |
|---|
CardioComm Retains Key Strategic Advisor
|
VICTORIA, B.C., January 9, 2003 - CardioComm Solutions Inc. (TSX-V:CCG) (the "Company", "CardioComm"), is pleased to announce that it has retained B. Harlow & Associates LLC, and its Managing Partner, Brad Harlow, as Strategic Advisor to the Board of Directors. Mr. Harlow will be focused on developing strategic partnerships for CardioComm, focusing on the U.S. and Europe.
Founded in 2001, B. Harlow & Associates, LLC, works with a number of health care companies and VC-backed start-ups. It provides strategic planning, financing options, distribution analysis, partner introductions, and technology evaluation focusing primarily in cardiac, chronic disease management and web/e-health applications. In addition, Mr. Harlow works with venture capital firms on private placement investments and M & A opportunities.
Mr. Harlow brings to CardioComm over 20 years experience in managing & directing cardiology companies, services and new technology. He was formerly Vice President of Instromedix ® (now a subsidiary of Card Guard ® ), General Manager/Chief Officer of Paceart™ (now a part of Medtronic Inc.), and, most recently, Senior Vice President & General Manager of Data Critical which was purchased by GE Medical Systems in 2001. Mr. Harlow holds a B.S. in Accounting and a Masters of Business Administration in Finance.
About CardioComm Solutions Inc: CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS™ ) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has both ISO 9001 and EN 46001 certifications.
|
On behalf of the Board of Directors of CardioComm Solutions Inc.:
“Stephen Martin”
Stephen R. Martin, President & CEO
For investor information, please contact: Stephen Martin |
